Jakarta , The Indonesia Post – The Ministry of Health (Kemenkes) has allocated 9.3 million doses of COVID-19 vaccine stock to support the second booster dose vaccination program for the general public.
“The stock is kept at the center of 7.2 million doses and 2.1 million doses in the regions,” Head of the Ministry of Health’s Communication and Public Service Bureau Dr. Siti Nadia Tarmizi confirmed in Jakarta, Monday.
She said the types of vaccines available included 138,185 doses of the Janssen vaccine, 3,344,772 doses of the Pfizer vaccine, 8,404 doses of the Sinopharm vaccine, 189,684 of the Zifivax vaccine.
The rest are domestically produced Red and White vaccines, including 1,171,755 doses of the InaVac vaccine, and 4,528,570 doses of the IndoVac vaccine.
The stock of purchased vaccines that are now stored in storage facilities belonging to the central government, he said, is 7,216,315 doses, the remaining vaccines from grants are 2,039,020 doses.
“The total stock in the area is 2,165,055 doses, consisting of 523,030 doses of purchased vaccines and 1,642,025 doses of grants,” said Siti Nadia Tarmizi.
Previously, Ministry of Health spokesperson Dr. Mohammad Syahril said the general public could already get the second booster COVID-19 vaccination.
“This is being done as an effort to accelerate vaccination while increasing the protection of the Indonesian people from COVID-19,” he said.
He said the second booster dose of COVID-19 vaccination could be given to all the general public aged 18 years and over starting January 24, 2023 without waiting for tickets or invitations.
“Recording is still being done manually while waiting for P-care and PeduliLindungi to be prepared,” he said.
This rule is contained in Circular Letter Number HK.02.02/C/380/2023 Concerning the 2nd Booster Dose of COVID-19 Vaccination for the General Public, which was stipulated by the Director General of Disease Prevention and Control on January 20, 2023.
Regarding the SE attachment of booster vaccinations are as follows:.
The type of vaccine that can be used is the COVID-19 vaccine which has received an Emergency Use Authorization (EUA) from the Food and Drug Supervisory Agency (BPOM) and takes into account the available vaccines.
The following is a vaccine regimen that can be used for the second booster vaccination, namely a combination for the first Sinovac booster including AstraZeneca given half dose or 0.25 ml, Pfizer given half dose or 0.15 ml, Moderna given full dose or 0.5 ml, full dose of Sinopharm or 0.5 ml, Sinovac full dose or 0.5 ml, full dose of Zifivax or 0, 5 ml, Indovac is given a full dose (full dose) or 0.5 ml, Inavac is a full dose (full dose) or 0.5 ml.
Combinations for AstraZeneca’s first booster, including Moderna given half dose or 0.25 ml, Pfizer given half dose or 0.15 ml, AstraZeneca given full dose or 0.5 ml.
The combination for Pfizer’s first booster included Pfizer being given a full dose (full dose) or 0.3 ml, Moderna being given half a dose (half dose) or 0.25 ml, AstraZeneca being given a full dose (full dose) or 0.5 ml.
The combination for Moderna’s first booster includes Moderna being given half a dose (half dose) or 0.25 ml, Pfizer being given half a dose (half dose) or 0.15 ml.
The combination for Janssen’s (J&J) first booster includes Janssen (J&J) given a full dose (full dose) or 0.5 ml, Pfizer given a full dose (full dose) or 0.3 ml, Moderna given half dose or 0.25ml.
The combination for Sinopharm’s first booster includes Sinopharm being given a full dose (full dose) or 0.5 ml, Zivifax being given a full dose (full dose) or 0.5 ml.
The combination for the first Covovax booster includes Covovax given a full dose or 0.5 ml.
He said the second booster dose of COVID-19 vaccination was given six months apart from the first booster dose of vaccination.
“Vaccination must be carried out at health service facilities and/or at COVID-19 vaccination service posts,” said Mohammad Syahril. (mhn/bbs)
Comment